Stay informed Sign up for our newsletter and be the first to know.
Stay informed Sign up for our newsletter and be the first to know.
Brilliant Investment Thinking by Advisers for Advisers.
ASX
-0.70%
S&P
-1.65%
AUD
$0.71

What's better than a unicorn?

The stellar run in the Nasdaq 100 index, which has seen it reach new all-time highs some 40 times already in 2020, shows no signs of slowing. With such...

HESTA appoints Martin Currie for new partnership

Martin Currie Investment Management has formed a partnership for international equities with HESTA, the $52 billion health and related industries super fund.

The power of engagement

Investing to improve lives  is the mantra of Martin Currie, one of the world leaders in ESG investing. This annual report reviews the year that was...

3 unlikely stocks to get your dividend fix

One of the main themes that played out this reporting season was the absence of company dividends. The cash doled out by the largest 50 ASX listed companies...

Look to Your Own Devices: Biotech Stars of the ASX

In the first of a series on Australian biotech success stories, we start with some of the outstanding medical device stocks on the ASX.

E is not for easy

Recent years have had pundits focus on the potential growth and relative valuation of emerging markets. The terminology alone is obtuse, just what is emerging?...

Small caps to remain attractive for investors

Following the March equity market correction due to the COVID-19 pandemic, global equity markets rebounded sharply in April, with the small cap sector...

Aussie tech stocks shine

If clients are seeking advice on where opportunities are in the Australia share market, they should not overlook a group of Australian technology stocks that...

Renewables bring might to the race for returns

There is little doubt that the world as we know it will change as a result of the COVID-19 outbreak and subsequent shutdowns. But how much? No one truly knows,...

Equity income opportunities in focus

The global Purchasing Managers' Index (PMI) has been in decline since 2017. Combined with the heightened risk of a prolonged US-China trade war; this has...